HAIM
LFSC

Hunter Associates Investment Management’s F/m Emerald Life Sciences Innovation ETF LFSC Stock Holding History

Hunter Associates Investment Management’s Portfolio LFSC Stock Details LFSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.74M Buy
49,739
+3,831
+8% +$136K 0.23% 99
2025
Q4 		$1.68M Buy
45,908
+5,312
+13% +$182K 0.23% 102
2025
Q3 		$1.21M Sell
40,596
-144
-0.4% -$3.85K 0.17% 114
2025
Q2 		$1M Buy
40,740
+4,101
+11% +$93.9K 0.15% 123
2025
Q1 		$820K Buy
36,639
+11,329
+45% +$276K 0.13% 143
2024
Q4 		$590K Buy
+25,310
New +$641K 0.09% 161

Other funds holding LFSC

EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
CCWP
Cedar Cove Wealth Partners Bloomington, Minnesota $213M AUM
AI
Atria Investments Charlotte, North Carolina $8.94B AUM 20.84% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Hunter Associates Investment Management's LFSC Position: Q1 2026 in Review

Hunter Associates Investment Management increased its F/m Emerald Life Sciences Innovation ETF (LFSC) stake by 8.3% in Q1 2026, buying an estimated $136K and bringing the position to 49,739 shares worth $1.74M. The position accounts for 0.23% of the portfolio, ranked #99.

Hunter Associates Investment Management first reported a position in LFSC in Q4 2024 and has held it in 6 quarters since. 7 funds tracked by Wall St. Rank hold LFSC as of Q1 2026.

  • Hunter Associates Investment Management held 49,739 shares of F/m Emerald Life Sciences Innovation ETF worth $1.74M as of Q1 2026.
  • Hunter Associates Investment Management bought 3,831 F/m Emerald Life Sciences Innovation ETF shares in Q1 2026, an estimated $136K.
  • F/m Emerald Life Sciences Innovation ETF made up 0.23% of Hunter Associates Investment Management's portfolio in Q1 2026, its #99 holding.
  • Hunter Associates Investment Management first reported a position in F/m Emerald Life Sciences Innovation ETF in Q4 2024 and has held it in 6 quarters since.
  • 7 funds tracked by Wall St. Rank held F/m Emerald Life Sciences Innovation ETF as of Q1 2026.

Based on Hunter Associates Investment Management's 13F filing for Q1 2026, filed 27 Apr 2026.